Illumina board rejects sweetened Roche offer

April 2 (Reuters) - Illumina Inc said on Monday
that its board unanimously rejected Roche Holding's
increased offer to buy the genetic sequencing company for $51
per share, or about $6.7 billion, saying it dramatically
undervalued the company.

wish wash restore clean car washing and detailing